Novo raises full-year outlook as Wegovy pill sales impress

The Quick Take
Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to CNBC Top News.
Related
Markets
Google defends school AI rules amid political criticism
Markets
Astellas Pharma ADR GAAP EPS of v134.47, revenue of ¥1270.86B; updates FY2027 outlook
Markets
IRGC announces destruction of four ships in Strait of Hormuz - The Jerusalem Post
IRGC announces destruction of four ships in Strait of Hormuz The Jerusalem Post
Markets
